3.22.2.2 html 227 274 1 true 43 0 false 8 false false R1.htm 000 - Document - Document And Entity Information Sheet http://bio-key.com/20220930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://bio-key.com/20220930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://bio-key.com/20220930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://bio-key.com/20220930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited- Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://bio-key.com/20220930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://bio-key.com/20220930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 007 - Disclosure - Note 1 - Nature of Business and Basis of Presentation Sheet http://bio-key.com/20220930/role/statement-note-1-nature-of-business-and-basis-of-presentation Note 1 - Nature of Business and Basis of Presentation Notes 7 false false R8.htm 008 - Disclosure - Note 2 - Going Concern Sheet http://bio-key.com/20220930/role/statement-note-2-going-concern Note 2 - Going Concern Notes 8 false false R9.htm 009 - Disclosure - Note 3 - Revenue From Contracts With Customers Sheet http://bio-key.com/20220930/role/statement-note-3-revenue-from-contracts-with-customers Note 3 - Revenue From Contracts With Customers Notes 9 false false R10.htm 010 - Disclosure - Note 4 - Swivel Secure Europe, SA Acquisition Sheet http://bio-key.com/20220930/role/statement-note-4-swivel-secure-europe-sa-acquisition Note 4 - Swivel Secure Europe, SA Acquisition Notes 10 false false R11.htm 011 - Disclosure - Note 5 - Accounts Receivable Sheet http://bio-key.com/20220930/role/statement-note-5-accounts-receivable Note 5 - Accounts Receivable Notes 11 false false R12.htm 012 - Disclosure - Note 6 - Share Based Compensation Sheet http://bio-key.com/20220930/role/statement-note-6-share-based-compensation Note 6 - Share Based Compensation Notes 12 false false R13.htm 013 - Disclosure - Note 7 - Factoring Sheet http://bio-key.com/20220930/role/statement-note-7-factoring Note 7 - Factoring Notes 13 false false R14.htm 014 - Disclosure - Note 8 - Note Receivable Sheet http://bio-key.com/20220930/role/statement-note-8-note-receivable Note 8 - Note Receivable Notes 14 false false R15.htm 015 - Disclosure - Note 9 - Inventory Sheet http://bio-key.com/20220930/role/statement-note-9-inventory- Note 9 - Inventory Notes 15 false false R16.htm 016 - Disclosure - Note 10 - Resalable Software License Rights Sheet http://bio-key.com/20220930/role/statement-note-10-resalable-software-license-rights Note 10 - Resalable Software License Rights Notes 16 false false R17.htm 017 - Disclosure - Note 11 - Investment in Debt Security Sheet http://bio-key.com/20220930/role/statement-note-11-investment-in-debt-security- Note 11 - Investment in Debt Security Notes 17 false false R18.htm 018 - Disclosure - Note 12 - Commitments and Contingencies Sheet http://bio-key.com/20220930/role/statement-note-12-commitments-and-contingencies- Note 12 - Commitments and Contingencies Notes 18 false false R19.htm 019 - Disclosure - Note 13 - Leases Sheet http://bio-key.com/20220930/role/statement-note-13-leases Note 13 - Leases Notes 19 false false R20.htm 020 - Disclosure - Note 14 - Earnings Per Share ("EPS") Sheet http://bio-key.com/20220930/role/statement-note-14-earnings-per-share-eps Note 14 - Earnings Per Share ("EPS") Notes 20 false false R21.htm 021 - Disclosure - Note 15 - Stockholders' Equity Sheet http://bio-key.com/20220930/role/statement-note-15-stockholders-equity Note 15 - Stockholders' Equity Notes 21 false false R22.htm 022 - Disclosure - Note 16 - Fair Values of Financial Instruments Sheet http://bio-key.com/20220930/role/statement-note-16-fair-values-of-financial-instruments Note 16 - Fair Values of Financial Instruments Notes 22 false false R23.htm 023 - Disclosure - Note 17 - Major Customers and Accounts Receivables Sheet http://bio-key.com/20220930/role/statement-note-17-major-customers-and-accounts-receivables Note 17 - Major Customers and Accounts Receivables Notes 23 false false R24.htm 024 - Disclosure - Note 18 - Income Taxes Sheet http://bio-key.com/20220930/role/statement-note-18-income-taxes Note 18 - Income Taxes Notes 24 false false R25.htm 025 - Disclosure - Note 19 - Subsequent Events Sheet http://bio-key.com/20220930/role/statement-note-19-subsequent-events Note 19 - Subsequent Events Notes 25 false false R26.htm 026 - Disclosure - Significant Accounting Policies (Policies) Sheet http://bio-key.com/20220930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies 26 false false R27.htm 027 - Disclosure - Note 3 - Revenue From Contracts With Customers (Tables) Sheet http://bio-key.com/20220930/role/statement-note-3-revenue-from-contracts-with-customers-tables Note 3 - Revenue From Contracts With Customers (Tables) Tables http://bio-key.com/20220930/role/statement-note-3-revenue-from-contracts-with-customers 27 false false R28.htm 028 - Disclosure - Note 4 - Swivel Secure Europe, SA Acquisition (Tables) Sheet http://bio-key.com/20220930/role/statement-note-4-swivel-secure-europe-sa-acquisition-tables Note 4 - Swivel Secure Europe, SA Acquisition (Tables) Tables http://bio-key.com/20220930/role/statement-note-4-swivel-secure-europe-sa-acquisition 28 false false R29.htm 029 - Disclosure - Note 5 - Accounts Receivable (Tables) Sheet http://bio-key.com/20220930/role/statement-note-5-accounts-receivable-tables Note 5 - Accounts Receivable (Tables) Tables http://bio-key.com/20220930/role/statement-note-5-accounts-receivable 29 false false R30.htm 030 - Disclosure - Note 6 - Share Based Compensation (Tables) Sheet http://bio-key.com/20220930/role/statement-note-6-share-based-compensation-tables Note 6 - Share Based Compensation (Tables) Tables http://bio-key.com/20220930/role/statement-note-6-share-based-compensation 30 false false R31.htm 031 - Disclosure - Note 7 - Factoring (Tables) Sheet http://bio-key.com/20220930/role/statement-note-7-factoring-tables Note 7 - Factoring (Tables) Tables http://bio-key.com/20220930/role/statement-note-7-factoring 31 false false R32.htm 032 - Disclosure - Note 8 - Note Receivable (Tables) Sheet http://bio-key.com/20220930/role/statement-note-8-note-receivable-tables Note 8 - Note Receivable (Tables) Tables http://bio-key.com/20220930/role/statement-note-8-note-receivable 32 false false R33.htm 033 - Disclosure - Note 9 - Inventory (Tables) Sheet http://bio-key.com/20220930/role/statement-note-9-inventory-tables Note 9 - Inventory (Tables) Tables http://bio-key.com/20220930/role/statement-note-9-inventory- 33 false false R34.htm 034 - Disclosure - Note 10 - Resalable Software License Rights (Tables) Sheet http://bio-key.com/20220930/role/statement-note-10-resalable-software-license-rights-tables Note 10 - Resalable Software License Rights (Tables) Tables http://bio-key.com/20220930/role/statement-note-10-resalable-software-license-rights 34 false false R35.htm 035 - Disclosure - Note 13 - Leases (Tables) Sheet http://bio-key.com/20220930/role/statement-note-13-leases-tables Note 13 - Leases (Tables) Tables http://bio-key.com/20220930/role/statement-note-13-leases 35 false false R36.htm 036 - Disclosure - Note 14 - Earnings Per Share ("EPS") (Tables) Sheet http://bio-key.com/20220930/role/statement-note-14-earnings-per-share-eps-tables Note 14 - Earnings Per Share ("EPS") (Tables) Tables http://bio-key.com/20220930/role/statement-note-14-earnings-per-share-eps 36 false false R37.htm 037 - Disclosure - Note 2 - Going Concern (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-2-going-concern-details-textual Note 2 - Going Concern (Details Textual) Details http://bio-key.com/20220930/role/statement-note-2-going-concern 37 false false R38.htm 038 - Disclosure - Note 3 - Revenue From Contracts With Customers (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-3-revenue-from-contracts-with-customers-details-textual Note 3 - Revenue From Contracts With Customers (Details Textual) Details http://bio-key.com/20220930/role/statement-note-3-revenue-from-contracts-with-customers-tables 38 false false R39.htm 039 - Disclosure - Note 3 - Revenue From Contracts With Customers - Disaggregation of Revenue (Details) Sheet http://bio-key.com/20220930/role/statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details Note 3 - Revenue From Contracts With Customers - Disaggregation of Revenue (Details) Details 39 false false R40.htm 040 - Disclosure - Note 4 - Swivel Secure Europe, SA Acquisition (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-4-swivel-secure-europe-sa-acquisition-details-textual Note 4 - Swivel Secure Europe, SA Acquisition (Details Textual) Details http://bio-key.com/20220930/role/statement-note-4-swivel-secure-europe-sa-acquisition-tables 40 false false R41.htm 041 - Disclosure - Note 4 - Swivel Secure Europe, SA Acquisition - Assets Acquired and Liabilities Assumed (Details) Sheet http://bio-key.com/20220930/role/statement-note-4-swivel-secure-europe-sa-acquisition-assets-acquired-and-liabilities-assumed-details Note 4 - Swivel Secure Europe, SA Acquisition - Assets Acquired and Liabilities Assumed (Details) Details 41 false false R42.htm 042 - Disclosure - Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) Sheet http://bio-key.com/20220930/role/statement-note-5-accounts-receivable-summary-of-accounts-receivable-details Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) Details 42 false false R43.htm 043 - Disclosure - Note 6 - Share Based Compensation - Expenses for Continuing Operations (Details) Sheet http://bio-key.com/20220930/role/statement-note-6-share-based-compensation-expenses-for-continuing-operations-details Note 6 - Share Based Compensation - Expenses for Continuing Operations (Details) Details 43 false false R44.htm 044 - Disclosure - Note 7 - Factoring (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-7-factoring-details-textual Note 7 - Factoring (Details Textual) Details http://bio-key.com/20220930/role/statement-note-7-factoring-tables 44 false false R45.htm 045 - Disclosure - Note 7 - Factoring - Due From Factor (Details) Sheet http://bio-key.com/20220930/role/statement-note-7-factoring-due-from-factor-details Note 7 - Factoring - Due From Factor (Details) Details 45 false false R46.htm 046 - Disclosure - Note 7 - Factoring - Fees (Details) Sheet http://bio-key.com/20220930/role/statement-note-7-factoring-fees-details Note 7 - Factoring - Fees (Details) Details 46 false false R47.htm 047 - Disclosure - Note 8 - Note Receivable (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-8-note-receivable-details-textual Note 8 - Note Receivable (Details Textual) Details http://bio-key.com/20220930/role/statement-note-8-note-receivable-tables 47 false false R48.htm 048 - Disclosure - Note 8 - Note Receivable - Summary of Note Receivable (Details) Sheet http://bio-key.com/20220930/role/statement-note-8-note-receivable-summary-of-note-receivable-details Note 8 - Note Receivable - Summary of Note Receivable (Details) Details 48 false false R49.htm 049 - Disclosure - Note 9 - Inventory - Components of Inventory (Details) Sheet http://bio-key.com/20220930/role/statement-note-9-inventory-components-of-inventory-details Note 9 - Inventory - Components of Inventory (Details) Details 49 false false R50.htm 050 - Disclosure - Note 10 - Resalable Software License Rights (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-10-resalable-software-license-rights-details-textual Note 10 - Resalable Software License Rights (Details Textual) Details http://bio-key.com/20220930/role/statement-note-10-resalable-software-license-rights-tables 50 false false R51.htm 051 - Disclosure - Note 10 - Resalable Software License Rights - Amortization Expense (Details) Sheet http://bio-key.com/20220930/role/statement-note-10-resalable-software-license-rights-amortization-expense-details Note 10 - Resalable Software License Rights - Amortization Expense (Details) Details 51 false false R52.htm 052 - Disclosure - Note 11 - Investment in Debt Security (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-11-investment-in-debt-security-details-textual Note 11 - Investment in Debt Security (Details Textual) Details http://bio-key.com/20220930/role/statement-note-11-investment-in-debt-security- 52 false false R53.htm 053 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-12-commitments-and-contingencies-details-textual Note 12 - Commitments and Contingencies (Details Textual) Details http://bio-key.com/20220930/role/statement-note-12-commitments-and-contingencies- 53 false false R54.htm 054 - Disclosure - Note 13 - Leases - Operating Lease Balance Sheet Information (Details) Sheet http://bio-key.com/20220930/role/statement-note-13-leases-operating-lease-balance-sheet-information-details Note 13 - Leases - Operating Lease Balance Sheet Information (Details) Details 54 false false R55.htm 055 - Disclosure - Note 14 - Earnings Per Share ("EPS") - Securities Excluded From the Diluted Per Share Calculation (Details) Sheet http://bio-key.com/20220930/role/statement-note-14-earnings-per-share-eps-securities-excluded-from-the-diluted-per-share-calculation-details Note 14 - Earnings Per Share ("EPS") - Securities Excluded From the Diluted Per Share Calculation (Details) Details http://bio-key.com/20220930/role/statement-note-14-earnings-per-share-eps-tables 55 false false R56.htm 056 - Disclosure - Note 15 - Stockholders' Equity (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-15-stockholders-equity-details-textual Note 15 - Stockholders' Equity (Details Textual) Details http://bio-key.com/20220930/role/statement-note-15-stockholders-equity 56 false false R57.htm 057 - Disclosure - Note 17 - Major Customers and Accounts Receivables (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-17-major-customers-and-accounts-receivables-details-textual Note 17 - Major Customers and Accounts Receivables (Details Textual) Details http://bio-key.com/20220930/role/statement-note-17-major-customers-and-accounts-receivables 57 false false R58.htm 058 - Disclosure - Note 18 - Income Taxes (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-18-income-taxes-details-textual Note 18 - Income Taxes (Details Textual) Details http://bio-key.com/20220930/role/statement-note-18-income-taxes 58 false false R59.htm 059 - Disclosure - Note 19 - Subsequent Events (Details Textual) Sheet http://bio-key.com/20220930/role/statement-note-19-subsequent-events-details-textual Note 19 - Subsequent Events (Details Textual) Details http://bio-key.com/20220930/role/statement-note-19-subsequent-events 59 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 38 fact(s) appearing in ix:hidden were eligible for transformation: bkyi:ClassOfWarrantOrRightIssuedDuringPeriod, bkyi:ConcentrationRiskNumberOfMajorCustomers, bkyi:RelatedPartyAgreementTerm, dei:EntityRegistrantName, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:IncomeTaxExpenseBenefit, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:RevenueFromRelatedParties, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised, us-gaap:WarrantsAndRightsOutstandingTerm - bkyi20220930_10q.htm 8, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51 bkyi20220930_10q.htm bkyi-20220930.xsd bkyi-20220930_cal.xml bkyi-20220930_def.xml bkyi-20220930_lab.xml bkyi-20220930_pre.xml ex_442625.htm ex_442626.htm ex_442627.htm ex_442628.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true